NEWS 

Real-time and near-time news

 

 

 

ANALYSIS

Stock analysis as news feed

 

 

VIDEO

Range of services

 

 

Newsticker

Companies
Economic News
Markets

ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use

|   Companies

 

WASHINGTON (dpa-AFX) - Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.

Kionex Suspension is the only commercially available therapeutically equivalent to the reference listed drug (RLD) SPS Suspension for Oral or Rectal use.

The U.S. annual sales for Sodium Polystyrene Sulfonate Oral / Rectal Suspension total approximately $30.3 million, based on March 2024 moving annual total (MAT) IQVIA data.

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use

|   Companies

 

WASHINGTON (dpa-AFX) - Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.

Kionex Suspension is the only commercially available therapeutically equivalent to the reference listed drug (RLD) SPS Suspension for Oral or Rectal use.

The U.S. annual sales for Sodium Polystyrene Sulfonate Oral / Rectal Suspension total approximately $30.3 million, based on March 2024 moving annual total (MAT) IQVIA data.

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use

|   Companies

 

WASHINGTON (dpa-AFX) - Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.

Kionex Suspension is the only commercially available therapeutically equivalent to the reference listed drug (RLD) SPS Suspension for Oral or Rectal use.

The U.S. annual sales for Sodium Polystyrene Sulfonate Oral / Rectal Suspension total approximately $30.3 million, based on March 2024 moving annual total (MAT) IQVIA data.

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

nach oben